Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending November 16, 2024 (Week 46)
Reporting Area Carbapenemase-Producing Organisms (CPO), Total §,¶
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 61 NC 4,099 6,049
New England 2 NC 70 98
Connecticut - NC - -
Maine - NC 23 42
Massachusetts - NC - -
New Hampshire - NC 15 23
Rhode Island 2 NC 31 30
Vermont - NC 1 3
Middle Atlantic - NC 138 514
New Jersey - NC - -
New York (excluding New York City) - NC - -
New York City - NC - 224
Pennsylvania - NC 138 290
East North Central 34 NC 1,909 2,490
Illinois - NC 50 652
Indiana - NC 224 352
Michigan - NC 183 300
Ohio 34 NC 1,319 1,145
Wisconsin - NC 133 41
West North Central 1 NC 137 239
Iowa - NC 54 77
Kansas 1 NC 76 78
Minnesota - NC - 69
Missouri - NC - -
Nebraska - NC - -
North Dakota - NC - 11
South Dakota - NC 7 4
South Atlantic 10 NC 523 755
Delaware - NC 15 12
District of Columbia - NC - -
Florida N NC N N
Georgia - NC - 278
Maryland - NC - -
North Carolina - NC - 161
South Carolina - NC - -
Virginia 10 NC 406 226
West Virginia - NC 102 78
East South Central - NC 86 203
Alabama N NC N N
Kentucky - NC - -
Mississippi - NC 86 203
Tennessee - NC - -
West South Central - NC - 21
Arkansas - NC - -
Louisiana - NC - 21
Oklahoma - NC - -
Texas U NC U U
Mountain 14 NC 1,217 899
Arizona 14 NC 1,115 740
Colorado - NC - -
Idaho - NC - -
Montana - NC 8 1
Nevada - NC 2 94
New Mexico - NC 49 -
Utah - NC 43 63
Wyoming - NC - 1
Pacific - NC 19 830
Alaska - NC - -
California - NC - 711
Hawaii - NC - 19
Oregon - NC 19 25
Washington - NC - 75
U.S. Territories - NC - 163
American Samoa - NC - -
Commonwealth of Northern Mariana Islands - NC - -
Guam - NC - -
Puerto Rico - NC - 163
U.S. Virgin Islands - NC - -
Non-U.S. Residents - NC 2 -
Total 61 NC 4,101 6,212
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.
  • ¶ CPO (total) includes CP-CRE cases reported in MMWR year 2023, and CPO clinical and CPO screening cases reported in both MMWR years 2023 and 2024.